Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201110146 Principal Investigator: Stockerl-Goldstein, Keith
Title: A Phase Ib Study of Elotuzumab in Combination with Lenalidomide and Dexamethasone in Subjects with Multiple Myeloma and Normal Renal Function, Sever Renal Impairment, or End Stage Renal Disease Requiring Dialysis
Phase: I Disease Site: Multiple Myeloma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
This study will look at the safety of elotuzumab given with lenalidomide and dexamethasone in patients with and without severe kidney impairment and end-stage kidney disease requiring dialysis.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)